All In MedTech

Device Trial Radar · NCT02423005

Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US

A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients

Last checked: Nov 19, 2026Latest source record: Feb 5, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 180 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

180

Actual

Start

Apr 2015

Primary completion

Apr 2017

Study completion Apr 2017

Sponsor

Lead sponsor
Atlantic TherapeuticsAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Bio-Medical Research, Ltd.
First posted
Apr 22, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
Female only, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A prospective, randomised, controlled, single-blind, multi-site clinical study employing Neuromuscular Electrical Stimulation (NMES) to stimulate the pelvic floor muscles of women suffering from stress urinary incontinence. Approximately one-hundred and eighty (180) female patients diagnosed with stress urinary incontinence will be enrolled in this study. All patients who are considered eligible to participate in the clinical study and give consent will be randomised to complete either a 12-week treatment programme with the Neurotech Vital Compact device or a 12-week treatment programme with the itouch Sure Pelvic Floor Exerciser. The 12-week treatment programme will be completed by the subjects at home with treatment with the device in accordance with the device Instructions for Use.

Conditions

  • Stress Urinary Incontinence

Interventions

  • Neurotech Vital CompactDevice

    Neuromuscular electrical stimulation of the pelvic floor via an arrangement of external electrodes held in place by a garment.

  • itouch Sure Pelvic Floor ExerciserDevice

    Vaginal probe with electrodes designed to deliver electrical stimulation to the pelvic floor muscles.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of subjects who have achieved >50% improvement on the provocative pad weight test.Time frame: 12 weeks

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Maricopa Integrated Health Systems

    Phoenix, Arizona

  • University of California Irvine Medical Center

    Orange, California

  • Hartford Hospital

    Hartford, Connecticut

9 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.